Our program is nationally recognized for excellence in cardiac surgery, heart failure, transplantation, and structural heart disease, supported by $20M+ in research funding, 1,500+ active clinical trial participants, and a robust academic platform with 88 fellows across 20 training programs. The cardiothoracic surgery team provides a broad range of services, including coronary artery bypass grafting (CABG), thoracic aortic surgery, mitral valve repair, minimally invasive aortic valve replacement, Impella support, and ECMO.